Results 251 to 260 of about 2,514,827 (314)

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang   +4 more
wiley   +1 more source

Burden and Characteristics of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis from 2017 to 2023. [PDF]

open access: yesViruses
Bally-von Passavant ED   +7 more
europepmc   +1 more source

COVID-19 mortality among people living with HIV/AIDS in Brazil: a multilevel analysis. [PDF]

open access: yesAIDS Res Ther
Oliveira TNDC   +6 more
europepmc   +1 more source

A Twist in the Diagnosis: Chronic Arthropathy Without Inflammation

open access: yes
Arthritis Care &Research, EarlyView.
María Á. Puche‐Larrubia   +3 more
wiley   +1 more source

Lung cancer in patients aged 80 years and over

open access: yesLung cancer in patients aged 80 years and over
openaire  

Home - About - Disclaimer - Privacy